25: PTC Online Resource Library

25: PTC Online Resource Library

Updated: 5/25/2019

There are many resources available on-line about all aspects of cancer (fewer specifically devoted to post-transplant risks, but other information would still be applicable for post-transplant issues), some of which are listed here:

Note: this is just a raw growing collection that will be reorganized in a near future update, but we wanted to make these available for those who may be ready to delve deeper now - stay tuned as new links are added regularly



Cancer researchersTRIO Post-transplant Cancer workshop slide set:
Slides used at 2016 TGA (Transplant Games of America) PTC workshop


Directory of clinical trials
> NIH: ClinicalTrials.gov
> National Cancer Institute clinical trials search tool

> PTLD Clinical Trials fact sheet

Cancer Support Groups
> AICR contact listing of support groups by cancer type

Cancer general resources:

Cancer articles & videos of interest:


Immunosuppressant drugs:

  • Calcineurin inhibitors:
    Gengraf, Neoral,  Sandimmune (generic name: cyclosporine)
    Hecoria, Prograf, Astagraf XL (generic name: tacrolimus)

  • mTOR inhibitors:
    Afinitor, Afinitor Disperz, Zortress (generic name: everolimus)
    Torisel (generic name: temsirolimus)
    Rapamune (generic Name: sirolimus)

Cancer in Transplant Recipients

Skin cancer resources:

Kidney cancer resources:

Financing for Fighting Cancer

Blood cancer resources:

Immunosuppression/Immunodeficiency and Cancerlibrary scene

 Publications from the Transplant Cancer Match Study

(click on title above to learn more about this collaborative study that produced the papers listed below)

  1. Morton LM, Gibson TM, Clarke CA, Lynch CF, Anderson LA, Pfeiffer R, Landgren O, Weisenburger DD, Engels EA. Risk of myeloid neoplasms after solid organ transplantationLeukemia. 2014 Dec;28(12):2317-23.
  2. Wetmore JB, Calvet JP, Yu AS, Lynch CF, Wang CJ, Kasiske BL, Engels EA. Polycystic kidney disease and cancer after renal transplantationJ Am Soc Nephrol. 2014 Oct;25(10):2335-41.
  3. Koshiol J, Pawlish K, Goodman MT, McGlynn KA, Engels EA. Risk of hepatobiliary cancer after solid organ transplant in the United StatesClin Gastroenterol Hepatol. 2014 Sep;12(9):1541-9.
  4. Gibson TM, Engels EA, Clarke CA, Lynch CF, Weisenburger DD, Morton LM. Risk of diffuse large B-cell lymphoma after solid organ transplantation in the United StatesAm J Hematol. 2014 Jul;89(7):714-20.
  5. Engels EA, Castenson D, Pfeiffer RM, Kahn A, Pawlish K, Goodman MT, Nalesnik MA, Israni AK, Snyder J, Kasiske B. Cancers among US organ donors: a comparison of transplant and cancer registry diagnosesAm J Transplant. 2014 Jun;14(6):1376-82.
  6. Morton LM, Gibson TM, Clarke CA, Lynch CF, Weisenburger DD, Engels EA. Hepatitis B or C virus infection and risk of non-Hodgkin lymphoma among solid organ transplant recipientsHaematologica. 2014 May;99(5):70-3.
  7. Madeleine MM, Finch JL, Lynch CF, Goodman MT, Engels EA. HPV-related cancers after solid organ transplantation in the United StatesAm J Transplant. 2013 Dec;13(12):3202-9.
  8. Hall EC, Engels EA, Montgomery RA, Segev DL. Cancer risk after ABO-incompatible living-donor kidney transplantationTransplantation. 2013 Sep 15;96(5):476-9.
  9. Clarke CA, Morton LM, Lynch C, Pfeiffer RM, Hall EC, Gibson TM, Weisenburger DD, Martínez-Maza O, Hussain SK, Yang J, Chang ET, Engels EA. Risk of lymphoma subtypes after solid organ transplantation in the United StatesBr J Cancer. 2013 Jul 9;109(1):280-8.
  10. Engels EA, Clarke CA, Pfeiffer RM, Lynch CF, Weisenburger DD, Gibson TM, Landgren O, Morton LM. Plasma cell neoplasms in US solid organ transplant recipientsAm J Transplant. 2013 Jun;13(6):1523-32.
  11. Hall EC, Pfeiffer RM, Segev DL, Engels EA. Cumulative incidence of cancer after solid organ transplantationCancer. 2013 Jun 15;119(12):2300-8.
  12. Mbulaiteye SM, Clarke CA, Morton LM, Gibson TM, Pawlish K, Weisenburger DD, Lynch CF, Goodman MT, Engels EA. Burkitt lymphoma risk in U.S. solid organ transplant recipientsAm J Hematol. 2013 Apr;88(4):245-50.
  13. Hall EC, Segev DL, Engels EA. Racial/ethnic differences in cancer risk after kidney transplantationAm J Transplant. 2013 Mar;13(3):714-20.
  14. Engels EA, Pfeiffer RM, Fraumeni JF Jr, Kasiske BL, Israni AK, Snyder JJ, Wolfe RA, Goodrich NP, Bayakly AR, Clarke CA, Copeland G, Finch JL, Fleissner ML, Goodman MT, Kahn A, Koch L, Lynch CF, Madeleine MM, Pawlish K, Rao C, Williams MA, Castenson D, Curry M, Parsons R, Fant G, Lin M. Spectrum of cancer risk among US solid organ transplant recipientsJAMA. 2011 Nov 2;306(17):1891-901.

Choose a resource for more information:

Sponsors & Supporters

  • AAKP
  • Atara Bio
  • Clinical Consulting Associates
  • GLI
  • GuideStar GOLD
  • Notion design sponsor
  • solicitation
    Follow TRIO on  

    DISCLAIMER: The content of this TRIO post-transplant cancer Web site is not influenced by sponsors. The site is designed primarily for use by transplant recipients and their supporters. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with your transplant team or a physician skilled in cancer and your organ type if you suspect you are ill.